Why the study?
Does a bipolar steroid-eluting electrode reduce acute and chronic pacing thresholds compared to a bipolar microporous platinum electrode in patients receiving a pacemaker?
Does a bipolar steroid-eluting electrode reduce acute and chronic pacing thresholds compared to a bipolar microporous platinum electrode in patients receiving a pacemaker?
Steroid-eluting pacemaker leads maintain significantly lower chronic pacing thresholds compared to microporous platinum leads, allowing for safe programming at lower pulse amplitudes to prolong battery life.
Answers are grounded in this paper and cite their sources.
Favors steroid-eluting leads to lower chronic pacing energy and extend battery life; confirms RCT superiority over microporous platinum electrodes.
Differences in acute and chronic pacing thresholds were compared in patients receiving either the Medtronic Model 4004 steroid-eluting lead or the Medtronic Model 4012 microporous platinum lead. Patients (n = 35) were randomized at the time of implant to receive either a steroid-eluting (n = 17) or a microporous (n = 18) lead. Pacing thresholds were determined within 24 hours and at 2, 4, 6, 12, 24, and 52 weeks postimplant. By 2 weeks postimplant, pacing thresholds measured at 0.8, 1.6, 2.5, 3.3, and 4.2 V were significantly lower in the steroid lead group compared to the microporous lead group (P < 0.05). At 24 weeks, the voltage threshold at 0.3 msec was 0.8 V in 88% of patients with a steroid lead whereas this threshold was only observed in 33% of patients with the microporous lead (P < 0.01). At 52 weeks the pacing energy measured at 1.6 V, twice pulse duration threshold, was significantly lower in the steroid lead group (0.81 +/- 0.59 microJ) compared to the microporous lead group (1.25 +/- 0.60 microJ, P < 0.05). Thirteen patients in the steroid lead group and 9 patients in the microporous lead group have been programmed at a pulse amplitude of 1.6 V since the 24-week follow-up visit. These patients have been followed for a minimum of 6 months without documented failure to capture. This study shows that pacemaker/lead systems with stable chronic low thresholds can be safely programmed to low pulse amplitude settings. This practice will prolong the longevity of pulse generators.
No takes yet. Share an insight, caveat, or question.
Gillis et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: